NCT04832022View on ClinicalTrials.gov

Longitudinal Follow-up of Patients With Chronic Inflammatory Rheumatisms (CIRs) Vaccinated Against COVID-19 Compared to Patients Refusing Vaccination

CompletedOBSERVATIONAL
Enrollment

397

Participants

Timeline

Start Date

April 7, 2021

Primary Completion Date

June 21, 2022

Study Completion Date

June 27, 2023

Conditions
Rheumatic DiseasesSARS-CoV InfectionCOVID-19
Interventions
OTHER

Biological samples

Serum and plasma samples. At baseline, 3, 6 and 12 months

Trial Locations (13)

13274

CHU Marseille, Marseille

29200

CHU Brest, Brest

30029

CHU Nîmes, Nîmes

31059

CHU Toulouse, Toulouse

34295

Centre hospitalier universitaire de Montpellier, Montpellier

37170

CHU Tours, Tours

44093

CHU Nantes, Nantes

54511

CHU Nancy, Nancy

63000

CHU Clermont-Ferrand, Clermont-Ferrand

75012

APHP Saint Antoine, Paris

75013

APHP La pitié Salpêtrière, Paris

76000

CHU Rouen, Rouen

06001

CHU Nice, Nice

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT04832022 - Longitudinal Follow-up of Patients With Chronic Inflammatory Rheumatisms (CIRs) Vaccinated Against COVID-19 Compared to Patients Refusing Vaccination | Biotech Hunter | Biotech Hunter